Richard Chen M.D., M.S., MS
Net Worth
Last updated:
What is Richard Chen M.D., M.S., MS net worth?
The estimated net worth of Dr. Richard Chen M.D., M.S., MS is at least $15,024,614 as of 16 Dec 2024. He owns shares worth $552,742 as insider, has earned $6,171,372 from insider trading and has received compensation worth at least $8,300,500 in Personalis, Inc..
What is the salary of Richard Chen M.D., M.S., MS?
Dr. Richard Chen M.D., M.S., MS salary is $638,500 per year as Senior Vice President of R&D and Chief Medical Officer in Personalis, Inc..
How old is Richard Chen M.D., M.S., MS?
Dr. Richard Chen M.D., M.S., MS is 54 years old, born in 1971.
What stocks does Richard Chen M.D., M.S., MS currently own?
As insider, Dr. Richard Chen M.D., M.S., MS owns shares in one company:
Company | Title | Shares | Price per share | Total value |
---|---|---|---|---|
Personalis, Inc. (PSNL) | Senior Vice President of R&D and Chief Medical Officer | 123,886 | $4.46 | $552,742 |
What does Personalis, Inc. do?
Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or plasma sample; ImmunoID Next for tumor profiling from tissue; NeXT Liquid Biopsy for tumor profiling from plasma; NeXT Personal, a liquid biopsy offering for personalized tumor tracking for patients; NeXT Dx Test, a genomic cancer profiling test enabling composite biomarkers for cancer treatment; and NeXT SHERPA and NeXT NEOPS for neoantigen prediction capabilities. The company also provides ACE platform for clinical and therapeutic applications such as neoantigen prediction, biomarker identification, and novel drug target selection. It serves biopharmaceutical customers, universities, non-profits, and government entities. The company has partnership with Mayo Clinic; MapKure, LLC; SpringWorks Therapeutics, Inc.; and Moores Cancer Center. Personalis, Inc. was incorporated in 2011 and is headquartered in Menlo Park, California.
Richard Chen M.D., M.S., MS insider trading
Personalis, Inc.
Dr. Richard Chen M.D., M.S., MS has made 56 insider trades between 2012-2024, according to the Form 4 filled with the SEC. Most recently he sold 4,834 units of PSNL stock worth $18,466 on 16 Dec 2024.
The largest trade he's ever made was exercising 101,000 units of PSNL stock on 7 Mar 2012. As of 16 Dec 2024 he still owns at least 123,886 units of PSNL stock.
Personalis key executives
Personalis, Inc. executives and other stock owners filed with the SEC:
- Dr. Richard Chen M.D., M.S., MS (54) Senior Vice President of R&D and Chief Medical Officer
- Mr. Aaron L. Tachibana (64) Senior Vice President & Chief Financial Officer
- Mr. John Stephen West (68) Co-Founder, Chief Executive Officer, Pres & Director